Realcan Pharmaceutical Group Co., Ltd.

XSEC:002589 Stock Report

Market Cap: CN¥4.8b

Realcan Pharmaceutical Group Management

Management criteria checks 4/4

Realcan Pharmaceutical Group's CEO is Xu Han, appointed in May 2023, has a tenure of 1.58 years. directly owns 12.4% of the company’s shares, worth CN¥595.43M. The average tenure of the management team and the board of directors is 2.6 years and 3.2 years respectively.

Key information

Xu Han

Chief executive officer

CN¥535.5k

Total compensation

CEO salary percentagen/a
CEO tenure1.6yrs
CEO ownership12.4%
Management average tenure2.6yrs
Board average tenure3.2yrs

Recent management updates

Recent updates

CEO

Xu Han (59 yo)

1.6yrs

Tenure

CN¥535,500

Compensation

Mr. Xu Han serves as the Chairman of the Board of Directors at Realcan Pharmaceutical Group Co., Ltd. and has been its Director since November 21, 2009 and has been its President since May 26, 2023.

Leadership Team

NamePositionTenureCompensationOwnership
Xu Han
President & Chairman1.6yrsCN¥535.50k12.4%
CN¥ 595.4m
Yi Feng
CFO & VP3.7yrsCN¥275.10kno data
Bo Yang
VP & Directorno dataCN¥240.60kno data
Chunlin Han
VP & Directorno dataCN¥907.70kno data
Zhe Li
VP, Secretary & Director1.3yrsCN¥287.40kno data
Mingtao Yan
Vice President15.1yrsCN¥274.30kno data

2.6yrs

Average Tenure

47.5yo

Average Age

Experienced Management: 002589's management team is considered experienced (2.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Xu Han
President & Chairman15.1yrsCN¥535.50k12.4%
CN¥ 595.4m
Bo Yang
VP & Director15.1yrsCN¥240.60kno data
Chunlin Han
VP & Director5.2yrsCN¥907.70kno data
Zhe Li
VP, Secretary & Director1.6yrsCN¥287.40kno data
Liyan Wu
Director1.6yrsCN¥192.00kno data
Chunfang Tao
Supervisor15.1yrsno datano data
Shaojie Huang
Employee Representative Supervisor15.1yrsno datano data
Xijun Liu
Independent Director4.8yrsCN¥60.00kno data
Shoukai Zhang
Director1.6yrsCN¥242.80kno data
Kaoxiang Sun
Independent Director1.6yrsCN¥36.90kno data
Jifa Wang
Independent Director1.6yrsCN¥36.90kno data
Yan Zhang
Chairman of the Supervisory Board1.6yrsno datano data

3.2yrs

Average Tenure

47.5yo

Average Age

Experienced Board: 002589's board of directors are considered experienced (3.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 05:24
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Realcan Pharmaceutical Group Co., Ltd. is covered by 17 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yalei YanBohai Securities Co., Ltd.
Shuchang LiuChangjiang Securities Co. LTD.
Xu Qing LiuChasing Securities